← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2011Last known activity
Oct 8, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT04563299Reponsible party - principal investigatorPhase 4Oct 8, 2020
- NCT04563299Overall official - principal investigatorPhase 4Oct 8, 2020
- NCT04563299Lead sponsorPhase 4Oct 8, 2020
- NCT01640171Overall official - principal investigatorN/AJul 1, 2012
- NCT01640171Lead sponsorN/AJul 1, 2012
- NCT01640171Reponsible party - principal investigatorN/AJul 1, 2012
- NCT01476449Lead sponsorPhase 2Nov 1, 2011
- NCT01476449Overall official - principal investigatorPhase 2Nov 1, 2011
Details
- Last known activity
- Oct 8, 2020